Gracell Biotechnologies

1D

1W

1M

3M

YTD

1Y

5Y

ALL

Why Robinhood?

You can watch GRCL and buy or sell other stocks, ETFs, and their options commission-free!

About GRCL

Gracell Biotechnologies, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of discovering and developing cell therapies to resolve industry challenges and fulfill unmet medical needs in the treatment of cancer.

CEO

Wei Cao, PhD

CEOWei Cao, PhD

Employees

—

Employees—

Headquarters

Suzhou, Shanghai

HeadquartersSuzhou, Shanghai

Founded

2017

Founded2017

Employees

—

Employees—

GRCL Key Statistics

Market cap

983.25M

Market cap983.25M

Price-Earnings ratio

-10.08

Price-Earnings ratio-10.08

Dividend yield

—

Dividend yield—

Average volume

930.52K

Average volume930.52K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$10.44

52 Week high$10.44

52 Week low

$1.40

52 Week low$1.40

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.